Market Overview

Front Range Bio Acquires Hemp Genomics Co. Steep Hill

Share:
Front Range Bio Acquires Hemp Genomics Co. Steep Hill
Read more about our latest Cannabis News! CANNABIS HOME

Front Range Biosciences, an agricultural biotech company that specializes in high-value crops like cannabis and hemp, announced this week its acquisition of Steep Hill’s Genomics Research & Development team.

Through this partnership, FRB will further build out its IP library and accelerate key research in the pursuit of healthy and dependable crop yields. Ultimately, this allows FRB to continue providing unique and advantaged cannabis and hemp varieties to farmers and growers, further supporting the industrial hemp market, which is projected to hit $20 billion in 2024.

“To partner with an esteemed group like Steep Hill represents a pivotal moment in our company’s life cycle, as well as the industry overall,” said Dr. Jonathan Vaught, CEO and Co-Founder of FRB. “The more leaders we can have come together and collaborate for the advancement of the space, the better.”

Related Links:

Big Opportunities: Michigan Cannabis Market 'Could Easily Eclipse $2B'

Green Peak Joins Forces With Michigan-Based Short's Brewing To Create Cannabis-Infused Beer, Edibles

Read more about our latest Cannabis News! CANNABIS HOME

Posted-In: Front Range BiosciencesCannabis M&A News Markets

 

Related Articles

View Comments and Join the Discussion!

Cannabis Movers

Sign up for our secret cannabis newsletter!
Never miss out on the breaking news in the Cannabis Industry!

Global Alliance For Cannabis Commerce Launches In Los Angeles

Another Case For Consistent Trading